Addictions
“Government Heroin” documentary exposes rampant safer supply fraud
By Adam Zivo
There is no substitute for hearing testimony with your own ears and eyes.
Although there is ample evidence that Canada’s “safer supply” programs are being widely defrauded and flooding communities with opioids, advocates continue to deny that this problem exists. That’s why I premiered my new documentary this week, “Government Heroin,” which follows the story of Callum Bagnall, a 25-year-old student who purchased thousands of diverted safer supply pills in London, Ontario.
While many written accounts of safer supply fraud have been published in the Canadian media, this documentary provides, for the first time, an extended interview with a former addict who openly describes his own use of these diverted drugs. It is one thing to read these stories, and altogether another to watch and listen to them – so perhaps this will help dispel the myths that have been pushed, rather aggressively, by the harm reduction movement.
In the film, Callum explains how, three years ago, a friend informed him that drug users in the city were receiving “insane” amounts of free safer supply drugs – predominantly hydromorphone, an opioid as potent as heroin. While these drugs are meant to wean addicts off riskier street substances, the friend explained that recipients mostly sell their safer supply at bargain prices so they can procure stronger substances, such as illicit fentanyl.
At first, Callum thought this was a joke. He had been struggling with a moderate addiction to pharmaceutical opioids – mostly oxycodone and Percocet – but, as these pills were expensive and hard to find, his drug use remained stable. The idea that the government was showering individuals with hundreds of powerful opioid pills a month, for free and with essentially no supervision, seemed “almost like a dream for a drug addict.”
But then he connected with some safer supply clients and realized that everything that he had heard was true. Fueled by a near-limitless supply of dirt-cheap opioids, Callum’s drug use rapidly spun out of control and, for two years, his life fell into utter disarray. Although he went to rehab last year, he says that his mind remains muddled by the aftereffects of these drugs to this day.
“I would have already been at the end of my road and (would) have gone to rehab at that point, if safer supply drugs weren’t so cheap and available. With the small amount of money I was making, I was able to afford hundreds of safer supply pills a week because of how cheap they were,” he says.
It was obvious to Callum that these pills were not counterfeit, given their quality and consistency and the fact that they typically came in their original, labelled prescription bottles: “Usually the people I was buying them from would try to scratch out the doctor’s name or their name. They were kind of paranoid about that. But sometimes they would just give it to me with the label unripped, not covered with marker or anything.”
Callum estimates that 90 percent of the safer supply clients he interacted with were diverting their drugs – a figure that is fairly consistent with estimates provided by former drug users I interviewed in London last year, who typically placed the diversion rate among their circles at around 80 percent.
Callum also believes that organized crime is involved in the trafficking of these drugs, and recalled how one higher-level dealer said that he would drive to northern Ontario, where safer supply is essentially unavailable, with thousands of pills stowed in his trunk to resell at a significant profit.
Subscribe for free to get BTN’s latest news and analysis, or donate to our journalism fund.
While I was unable to independently verify Callum’s claim about intraprovincial trafficking, his testimony is consistent with information provided to me earlier this year by Michael Tibollo, Ontario’s Associate Minister of Mental Health and Addictions, who said that, based on certain police reports and epidemiological data, it is clear that there is a particular problem with safer supply drugs being trafficked from London to northern Ontario.
Callum was able to corroborate the general contours of his story by providing dozens of screenshots of time-stamped text conversations between himself and his former dealers (some of which appear in the documentary), as well as excerpts of his medical records indicating that he had been diagnosed with severe opioid use disorder and had been “buying safer supply from friends.”
He also called a safer supply patient whom he used to purchase drugs from, and, while I listened in, had her confirm that she had hundreds of pills ready to sell and could introduce him to a safer supply doctor if he wanted to get on the program. A video recording of this conversation was originally meant to be included in the documentary, but was cut to mitigate risk of retaliation.
Finally, Callum’s mother, a registered nurse, appears in the documentary and recounts finding safer supply prescription bottles in her son’s room on the day he went to rehab.
As public scrutiny of safer supply has increased over the past year, providers have insisted that they are closely monitoring diversion through urine testing. Yet Callum says that the clients he interacted with would occasionally, in the process of selling their drugs, withhold a few of their pills and openly admit to him that they needed these small amounts to pass their tests.
“(They) would also take one or two pills the night before they get their prescription, so that it looks like it’s in their system. It shows up on the urine tests. So they would use that to pass the urine tests, so that they would get another script the next week,” he says in the film.
The exploitation of this loophole was confirmed by Dr. Janel Gracey, an addiction physician who treated Callum and who is also featured in my documentary. She says that “it is known in the addiction world that urine testing is not effective at catching diversion” because such tests only measure the presence of a drug, not its quantity. A safer supply patient can divert almost all of their drugs and still pass their urine tests, she says, so long as they take just one pill before giving their samples.
Gracey characterizes Canada’s current safer supply system as an underregulated “free for all” that destabilizes patients while allowing some pharmacists and physicians to reap considerable profits. “I know people on the safer supply program that have never even used fentanyl, and that’s the whole point of the program: to get them off the fentanyl. So they’re just lining up and getting a bunch of (hydromorphone), really, for no reason,” she says.
Gracey estimates that, of her 400 patients, approximately half have used, or know someone who has used, diverted safer supply drugs. She says that inexpensive hydromorphone is now “readily available on every street corner here in London,” and that dealers are “bombarding” her patients with the drug, causing many of them to “fall off the rails.”
“We are seeing younger and younger patients come in, unfortunately. Fifteen (and) 16-year-olds coming in, and they’re getting hooked on (hydromorphone) because it’s so incredibly cheap. It’s cheaper than alcohol,” she says. “We do get a few coming in that are there because of fentanyl use, but usually even the (young fentanyl users) started with (hydromorphone).”
I encourage you to watch “Government Heroin,” as the 19-minute documentary provides a more visceral and comprehensive account of the harms described here. There is no substitute for hearing testimony with your own ears and eyes.
This article was originally published in The Bureau, a Canadian media outlet that investigates the intersections of organized crime, drug trafficking and foreign interference.
Subscribe to Break The Needle. Our content is always free – but if you want to help us commission more high-quality journalism, consider getting a voluntary paid subscription.
Addictions
BC Addictions Expert Questions Ties Between Safer Supply Advocates and For-Profit Companies
By Liam Hunt
Canada’s safer supply programs are “selling people down the river,” says a leading medical expert in British Columbia. Dr. Julian Somers, director of the Centre for Applied Research in Mental Health and Addiction at Simon Fraser University, says that despite the thin evidence in support of these experimental programs, the BC government has aggressively expanded them—and retaliated against dissenting researchers.
Somers also, controversially, raises questions about doctors and former health officials who appear to have gravitated toward businesses involved in these programs. He notes that these connections warrant closer scrutiny to ensure public policies remain free from undue industry influence.
Safer supply programs claim to reduce overdoses and deaths by distributing free addictive drugs—typically 8-milligram tablets of hydromorphone, an opioid as potent as heroin—to dissuade addicts from accessing riskier street substances. Yet, a growing number of doctors say these programs are deeply misguided—and widely defrauded.
Ultimately, Somers argues, safer supply is exacerbating the country’s addiction crisis.
Somers opposed safer supply at its inception and openly criticized its nationwide expansion in 2020. He believes these programs perpetuate drug use and societal disconnection and fail to encourage users to make the mental and social changes needed to beat addiction. Worse yet, the safer supply movement seems rife with double standards that devalue the lives of poorer drug users. While working professionals are provided generous supports that prioritize recovery, disadvantaged Canadians are given “ineffective yet profitable” interventions, such as safer supply, that “convey no expectation that stopping substance use or overcoming addiction is a desirable or important goal.”
To better understand addiction, Somers created the Inter-Ministry Evaluation Database (IMED) in 2004, which, for the first time in BC’s history, connected disparate information—i.e. hospitalizations, incarceration rates—about vulnerable populations.
Throughout its existence, health experts used IMED’s data to create dozens of research projects and papers. It allowed Somers to conduct a multi-million-dollar randomized control trial (the “Vancouver at Home” study) that showed that scattering vulnerable people into regular apartments throughout the city, rather than warehousing them in a few buildings, leads to better outcomes at no additional cost.
In early 2021, Somers presented recommendations drawn from his analysis of the IMED to several leading officials in the B.C. government. He says that these officials gave a frosty reception to his ideas, which prioritized employment, rehabilitation, and social integration over easy access to drugs. Shortly afterwards, the government ordered him to immediately and permanently delete the IMED’s ministerial data.
Somers describes the order as a “devastating act of retaliation” and says that losing access to the IMED effectively ended his career as a researcher. “My lab can no longer do the research we were doing,” he noted, adding that public funding now goes exclusively toward projects sympathetic to safer supply. The B.C. government has since denied that its order was politically motivated.
In early 2022, the government of Alberta commissioned a team of researchers, led by Somers, to investigate the evidence base behind safer supply. They found that there was no empirical proof that the experiment works, and that harm reduction researchers often advocated for safer supply within their studies even if their data did not support such recommendations.
Somers says that, after these findings were published, his team was subjected to a smear campaign that was partially organized by the British Columbia Centre on Substance Use (BCCSU), a powerful pro-safer supply research organization with close ties to the B.C. government. The BCCSU has been instrumental in the expansion of safer supply and has produced studies and protocols in support of it, sometimes at the behest of the provincial government.
Somers is also concerned about the connections between some of safer supply’s key proponents and for-profit drug companies.
He notes that the BCCSU’s founding executive director, Dr. Evan Wood, became Chief Medical Officer at Numinus Wellness, a publicly traded psychedelic company, in 2020. Similarly, Dr. Perry Kendall, who also served as a BCCSU executive director, went on to found Fair Price Pharma, a now-defunct for-profit company that specializes in providing pharmaceutical heroin to high-risk drug users, the following year.
While these connections are not necessarily unethical, they do raise important questions about whether there is enough industry regulation to minimize potential conflicts of interest, whether they be real or perceived.
The BCCSU was also recently criticized in an editorial by Canadian Affairs, which noted that the organization had received funding from companies such as Shoppers Drug Mart and Tilray (a cannabis company). The editorial argued that influential addiction research organizations should not receive drug industry funding and reported that Alberta founded its own counterpart to the BCCSU in August, known as the Canadian Centre of Recovery Excellence, which is legally prohibited from accepting such sponsorships.
Already, private interests are betting on the likely expansion of safer supply programs. For instance, Safe Supply Streaming Co., a publicly traded venture capital firm, has advertised to potential investors that B.C.’s safer supply system could create a multi-billion-dollar annual market.
Somers believes that Canada needs more transparency regarding how for-profit companies may be directly or indirectly influencing policy makers: “We need to know exactly, to the dollar, how much of [harm reduction researchers’] operating budget is flowing from industry sources.”
Editor’s note: This story is published in syndication with Break The Needle and Western Standard.
The Bureau is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Dr. Julian M. Somers is director of the Centre for Applied Research in Mental Health and Addiction at Simon Fraser University. He was Director of the UBC Psychology Clinic, and past president of the BC Psychological Association. Liam Hunt is a contributing author to the Centre For Responsible Drug Policy in partnership with the Macdonald-Laurier Institute.
Addictions
Ottawa “safer supply” clinic criticized by distraught mother
An Ottawa mother, who lost her daughter to addiction, is frustrated by Recovery Care’s failure to help her opioid-addicted son
Masha Krupp has already lost one child to an overdose and fears she could lose another.
In 2020, her 47-year-old daughter Larisa died from methadone toxicity just 12 days into an opioid addiction treatment program. The program is run by Recovery Care, an Ottawa-based harm reduction clinic with five locations across the city, which aims to stabilize drug users and eventually wean them off more potent drugs.
Krupp says she is skeptical about the effectiveness of the support and counseling services that Recovery Care claims to provide and believes the clinic was negligent in her daughter’s case.
On Oct. 22, the Ottawa mother testified before the House of Commons Standing Committee on Health, which is studying Canada’s opioid epidemic.
In her testimony, Krupp said her daughter was prescribed 30mg of methadone — 50 per cent more than the recommended induction dose — and was not given an opiate tolerance test before starting the program. Larisa received treatment at the Bells Corners Recovery Care location.
Krupp’s 30-year-old son, whom Canadian Affairs agreed not to name, has been a patient at Recovery Care’s ByWard Market location since 2021, where he receives a combination of methadone and hydromorphone, another prescription drug administered through the treatment program.
“Three years later, my son is still using fentanyl, crack cocaine and methadone, despite being with Dr. [Charles] Breau and with Recovery Care for over three years,” Krupp testified.
“About four weeks ago, I had to call 9-1-1 because he was overdosing,” Krupp told Canadian Affairs in an interview. “This is on the safer supply program … three years in, I should not be calling 9-1-1.”
Open diversion
Founded in 2018, Recovery Care is a partner in the Safer Supply Ottawa initiative. The initiative, which is led by Ottawa Public Health and managed by the nonprofit Pathways to Recovery, provides prescription pharmaceutical opioids to individuals who are at high risk of overdose.
Pathways to Recovery works with a network of service providers throughout the city — including Recovery Care — to administer safer supply.
Krupp says she supports the concept of safer supply, but believes it needs to be administered differently.
“You can’t give addicts 28 pills and say ‘Oh here you go,’” she said in her testimony. “They sell for three dollars a pop on the street,” she said, referring to the practice of some individuals selling their prescribed medications to fund purchases of more intense street drugs like heroin and fentanyl.
Krupp says she sees her son — and other patients of the program — openly divert their prescribed medications outside of the Recovery Care clinic in ByWard Market, where she parks to wait for him.
“[B]ecause there’s no treatment attached to [my son’s safer supply], it’s just the doctor gives him all these pills, he diverts them, gets the drugs he needs, and he’s still an addict,” Krupp said in her testimony.
Donna Sarrazin, chief executive of Recovery Care, told Canadian Affairs that Recovery Care has measures to address diversion, including security cameras and onsite security staff.
“Patients are educated at intake and ongoing that diversion is not permitted and that they could be removed from the program,” she said in an emailed statement.
“Recovery Care works to understand diversion and has continued to progress programs and actions to address the issues. Concerns expressed by the community and our teams are taken seriously,” she said.
Krupp says she has communicated her concerns about her son reselling his prescribed medications to his doctor, Dr. Charles Breau, both in-person and through faxed letters. “I never hear back from the doctor. Never,” she said.
Krupp also said in her testimony that police have spoken to her son about his diversion.
Breau did not respond to inquiries made to his clinical teams at Recovery Care or Montfort Hospital, a teaching hospital affiliated with the University of Ottawa.
Sarrazin said Breau is not able to comment on patient or family care.
In Krupp’s view, the safer supply program would be more successful if drug users were required to take prescribed medications under supervision.
“If he was receiving his hydromorphone under witnessed dosage and there was a treatment plan attached to it, I believe it would be successful,” she said.
Dr. Eileen de Villa, the City of Toronto’s medical officer of health, reinforced this point at the Oct. 22 Health Committee meeting. She said Toronto Public Health’s injectable opioid agonist therapy program — which combines observed administration with a treatment plan — has seen “incredible results.”
De Villa shared a case of a pregnant client who entered the program. “She went on to have a successful pregnancy, a healthy baby, has actually successfully completed the treatment, and is now housed and has even gained custody of her other children,” she said.
Subscribe for free to get BTN’s latest news and analysis, or donate to our journalism fund.
‘An affront to me’
Krupp also says Recovery Care fails to deliver on its promise of supporting patients’ mental health needs. Recovery Care’s website says its clinics offer “mental health programs which are essential to every treatment plan.”
Krupp and her son’s father have both requested a clear treatment plan and consistent counselling for their son. But he was started on safer supply after participating in only one virtual counselling session, she says.
She says Recovery Care has only one mental health counselor who services four of Recovery Care’s clinics. “If you’re getting $2-million-plus a year in funding, you should be able to staff each clinic with one on-site counselor five days a week,” she said.
Instead of personalized assistance, her son received “a sheaf of photocopies” offering generic services like Narcotics Anonymous and crisis helplines. “It’s almost an affront to me, as a taxpayer and a mother of an addict,” Krupp said.
Krupp says that, following her testimony to the parliamentary committee, Breau reached out to offer her son a mental health counseling session for the first time.
Sarrazin told Canadian Affairs that patients are encouraged to request counseling at any time. “Currently there is no wait list and appointments can be booked within 1 week,” she said in her emailed statement.
Class actions
Today, Krupp is considering launching a class-action lawsuit against Health Canada and the Government of Canada, challenging both the enactment of safer supply and the loosening of methadone dispensing requirements in 2017. She believes these changes contributed to her daughter’s death in 2020.
She is also considering joining an existing class-action lawsuit in B.C., which alleges Health Canada failed to monitor the distribution of drugs provided through safer supply programs.
The Pathways to Recovery initiative received $9.69-million in funding from Health Canada from July 2020 to March 2025. In June 2023, Health Canada allocated an additional $1.9 million to expand Ottawa’s safer supply program across five sites and improve access to practitioners, mental health support, housing and other services.
“I want to see that money being put to a recovery based treatment, not simply people going in and out and getting their medications and just creating this new sub-layer of addicts,” Krupp said.
This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.
Subscribe for free to get BTN’s latest news and analysis, or donate to our journalism fund.
-
Brownstone Institute2 days ago
The Most Devastating Report So Far
-
Business2 days ago
Carbon tax bureaucracy costs taxpayers $800 million
-
ESG1 day ago
Can’t afford Rent? Groceries for your kids? Trudeau says suck it up and pay the tax!
-
Daily Caller1 day ago
Los Angeles Passes ‘Sanctuary City’ Ordinance In Wake Of Trump’s Deportation Plan
-
John Stossel1 day ago
Green Energy Needs Minerals, Yet America Blocks New Mines
-
Alberta1 day ago
Province considering new Red Deer River reservoir east of Red Deer
-
MAiD2 days ago
Over 40% of people euthanized in Ontario lived in poorest parts of the province: government data
-
Addictions1 day ago
BC Addictions Expert Questions Ties Between Safer Supply Advocates and For-Profit Companies